Neogen (NEOG) Interest Coverage Ratio (QoQ) (2019 - 2026)
Neogen (NEOG) Interest Coverage Ratio (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 43.67% |
| Nov 30, 2025 | 69.78% |
| Aug 31, 2025 | 97.89% |
| May 31, 2025 | -13,014.96% |
| Feb 28, 2025 | 101.00% |
| Nov 30, 2024 | -18,156.44% |
| Aug 31, 2024 | 120.05% |
| May 31, 2024 | -72.77% |
| Feb 29, 2024 | -18.70% |
| Nov 30, 2023 | -21.95% |
| Aug 31, 2023 | 228.30% |
| May 31, 2023 | -913.61% |
| Feb 28, 2023 | 302.60% |
| Nov 30, 2022 | -100.52% |
| Aug 31, 2022 | 24.11% |
| May 31, 2022 | -90.12% |
| Aug 31, 2021 | 238.45% |
| May 31, 2021 | -141.00% |
| Feb 28, 2021 | 1,348.33% |
| Nov 30, 2020 | 1,211.99% |